This is a randomized clinical trial to determine the safety and efficacy of terpinen-4-ol
(T4O), the most active ingredient of tea tree oil (TTO), in eradicating ocular demodicosis
(reducing ocular demodex counts and achieving the clinical improvement with minimal or no
irritation).